获取途径

作者

刘 丽 李万湖

作者单位

山东第一医科大学附属肿瘤医院影像科，山东 济南 山东第一医科大学(山东省医学科学院)研究生院，山东 济南

刊名

Advances in Clinical Medicine

年份

2026

卷号

Vol.16 No.6

页码

1381-1389

ISSN

2161-8712

关键词

小细胞肺癌 PET/CT 疗效评估 预后预测 Small Cell Lung Cancer PET/CT Efficacy Evaluation Prognostic Prediction

摘要

Small cell lung cancer is the most common subtype of pulmonary neuroendocrine tumors, accounting for approximately 15%~20% of all primary malignant lung tumors. Characterized by strong invasiveness and an early tendency for metastasis, the diagnosis and management of SCLC rely heavily on precise imaging evaluation. As a molecular imaging modality integrating functional metabolic imaging with anatomical structural imaging, F-fluorodeoxyglucose positron emission tomography/computed tomography ha...更多

Small cell lung cancer is the most common subtype of pulmonary neuroendocrine tumors, accounting for approximately 15%~20% of all primary malignant lung tumors. Characterized by strong invasiveness and an early tendency for metastasis, the diagnosis and management of SCLC rely heavily on precise imaging evaluation. As a molecular imaging modality integrating functional metabolic imaging with anatomical structural imaging, F-fluorodeoxyglucose positron emission tomography/computed tomography has become an important imaging tool in the diagnosis and treatment of SCLC due to its high sensitivity for detecting tumor metabolic activity, particularly its superior ability to identify occult distant metastases compared with conventional imaging techniques. Consequently, F-FDG PET/CT plays a crucial role throughout the entire management of SCLC. This review aims to systematically summarize the clinical applications and recent research advances of F-FDG PET/CT at different stages of SCLC management.收起

文献类型

期刊

浏览量

7